Potential and challenges of specifically isolating extracellular vesicles from heterogeneous populations.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
02 06 2021
Historique:
received: 10 12 2020
accepted: 18 05 2021
entrez: 3 6 2021
pubmed: 4 6 2021
medline: 9 11 2021
Statut: epublish

Résumé

Extracellular vesicles (EVs) have attracted interest due to their ability to provide diagnostic information from liquid biopsies. Cells constantly release vesicles divers in size, content and features depending on the biogenesis, origin and function. This heterogeneity adds a layer of complexity when attempting to isolate and characterize EVs resulting in various protocols. Their high abundance in all bodily fluids and their stable source of origin dependent biomarkers make EVs a powerful tool in biomarker discovery and diagnostics. However, applications are limited by the quality of samples definition. Here, we compared frequently used isolation techniques: ultracentrifugation, density gradient centrifugation, ultrafiltration and size exclusion chromatography. Then, we aimed for a tissue-specific isolation of prostate-derived EVs from cell culture supernatants with immunomagnetic beads. Quality and quantity of EVs were confirmed by nanoparticle tracking analysis, western blot and electron microscopy. Additionally, a spotted antibody microarray was developed to characterize EV sub-populations. Current analysis of 16 samples on one microarray for 6 different EV surface markers in triplicate could be easily extended allowing a faster and more economical method to characterize samples.

Identifiants

pubmed: 34079007
doi: 10.1038/s41598-021-91129-y
pii: 10.1038/s41598-021-91129-y
pmc: PMC8172572
doi:

Substances chimiques

Antigens, Surface 0
Biomarkers 0
FOLH1 protein, human EC 3.4.17.21
Glutamate Carboxypeptidase II EC 3.4.17.21

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11585

Références

Skog, J. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell. Biol. 10(12), 1470–1476 (2008).
pubmed: 19011622 pmcid: 3423894 doi: 10.1038/ncb1800
Minciacchi, V. R., Freeman, M. R. & Di Vizio, D. Extracellular vesicles in cancer: Exosomes, microvesicles and the emerging role of large oncosomes. Semin. Cell Dev. Biol. 40, 41–51 (2015).
pubmed: 25721812 pmcid: 4747631 doi: 10.1016/j.semcdb.2015.02.010
Zitvogel, L. et al. Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes. Nat. Med. 4(5), 594–600 (1998).
pubmed: 9585234 doi: 10.1038/nm0598-594
Colombo, M., Raposo, G. & Thery, C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30, 255–289 (2014).
pubmed: 25288114 doi: 10.1146/annurev-cellbio-101512-122326
van Niel, G., D’Angelo, G. & Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell. Biol. 19(4), 213–228 (2018).
pubmed: 29339798 doi: 10.1038/nrm.2017.125
Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell. Biol. 9(6), 654–659 (2007).
pubmed: 17486113 doi: 10.1038/ncb1596
Yanez-Mo, M. et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles 4, 27066 (2015).
pubmed: 25979354 doi: 10.3402/jev.v4.27066
Heidrich, I. et al. Liquid biopsies: Potential and challenges. Int. J. Cancer 148, 528–545 (2020).
pubmed: 32683679 doi: 10.1002/ijc.33217
Minciacchi, V. R. et al. Extracellular vesicles for liquid biopsy in prostate cancer: Where are we and where are we headed?. Prostate Cancer Prostatic DIS 20(3), 251–258 (2017).
pubmed: 28374743 pmcid: 5569339 doi: 10.1038/pcan.2017.7
Quandt, D. et al. Implementing liquid biopsies into clinical decision making for cancer immunotherapy. Oncotarget 8, 48507–48520 (2017).
pubmed: 28501851 pmcid: 5564665 doi: 10.18632/oncotarget.17397
Gould, S. J. & Raposo, G. As we wait: Coping with an imperfect nomenclature for extracellular vesicles. J. Extracell. Vesicles 2, 20389 (2013).
doi: 10.3402/jev.v2i0.20389
Thery, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 7(1), 1535750 (2018).
pubmed: 30637094 pmcid: 6322352 doi: 10.1080/20013078.2018.1535750
Harding, C., Heuser, J. & Stahl, P. Endocytosis and intracellular processing of transferrin and colloidal gold-transferrin in rat reticulocytes: Demonstration of a pathway for receptor shedding. Eur. J. Cell. Biol. 35(2), 256–263 (1984).
pubmed: 6151502
Pan, B. T. et al. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J. Cell. Biol. 101(3), 942–948 (1985).
pubmed: 2993317 doi: 10.1083/jcb.101.3.942
Zhang, H. et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat. Cell Biol. 20(3), 332–343 (2018).
pubmed: 29459780 pmcid: 5931706 doi: 10.1038/s41556-018-0040-4
Akers, J. C. et al. Biogenesis of extracellular vesicles (EV): Exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J. Neurooncol. 113(1), 1–11 (2013).
pubmed: 23456661 pmcid: 5533094 doi: 10.1007/s11060-013-1084-8
Tricarico, C., Clancy, J. & D’Souza-Schorey, C. Biology and biogenesis of shed microvesicles. Small GTPases 8(4), 220–232 (2017).
pubmed: 27494381 doi: 10.1080/21541248.2016.1215283
Willms, E. et al. Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci. Rep. 6, 22519 (2016).
pubmed: 26931825 pmcid: 4773763 doi: 10.1038/srep22519
Zabeo, D. et al. Exosomes purified from a single cell type have diverse morphology. J. Extracell. Vesicles 6(1), 1329476 (2017).
pubmed: 28717422 pmcid: 5505001 doi: 10.1080/20013078.2017.1329476
Konoshenko, M. Y. et al. Isolation of extracellular vesicles: General methodologies and latest trends. Biomed. Res. Int. 2018, 8545347 (2018).
pubmed: 29662902 pmcid: 5831698 doi: 10.1155/2018/8545347
Tauro, B. J. et al. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods 56(2), 293–304 (2012).
pubmed: 22285593 doi: 10.1016/j.ymeth.2012.01.002
Kalra, H. et al. Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma. Proteomics 13(22), 3354–3364 (2013).
pubmed: 24115447 doi: 10.1002/pmic.201300282
Thery, C. et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. 30, 3–22 (2006).
doi: 10.1002/0471143030.cb0322s30
Witwer, K. W. et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J. Extracell. Vesicles 2, 20360 (2013).
doi: 10.3402/jev.v2i0.20360
Consortium, E.-T. et al. EV-TRACK: Transparent reporting and centralizing knowledge in extracellular vesicle research. Nat. Methods 14(3), 228–232 (2017).
doi: 10.1038/nmeth.4185
Van Deun, J. et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J. Extracell. Vesicles 3, 24858 (2014).
doi: 10.3402/jev.v3.24858
Lobb, R. J. et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J. Extracell. Vesicles 4, 27031 (2015).
pubmed: 26194179 doi: 10.3402/jev.v4.27031
Mistry, K. & Cable, G. Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma. J. Am. Board Fam. Pract. 16(2), 95–101 (2003).
pubmed: 12665174 doi: 10.3122/jabfm.16.2.95
Andreoiu, M. & Cheng, L. Multifocal prostate cancer: Biologic, prognostic, and therapeutic implications. Hum. Pathol. 41(6), 781–793 (2010).
pubmed: 20466122 doi: 10.1016/j.humpath.2010.02.011
Andriole, G. L. et al. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality results after 13 years of follow-up. J. Natl. Cancer Inst. 104(2), 125–132 (2012).
pubmed: 22228146 pmcid: 3260132 doi: 10.1093/jnci/djr500
Silver, D. A. et al. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin. Cancer Res. 3(1), 81–85 (1997).
pubmed: 9815541
O’Keefe, D. S., Bacich, D. J. & Heston, W. D. W. Prostate Specific Membrane Antigen, in Prostate Cancer: Biology, Genetics, and the New Therapeutics (Humana Press, 2001).
Duijvesz, D. et al. Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer. PLoS ONE 8, e82589 (2013).
pubmed: 24391718 pmcid: 3876995 doi: 10.1371/journal.pone.0082589
Krishn, S. R. et al. Prostate cancer sheds the alphavbeta3 integrin in vivo through exosomes. Matrix Biol. 77, 41–57 (2019).
pubmed: 30098419 doi: 10.1016/j.matbio.2018.08.004
Di Cristofano, A. & Pandolfi, P. P. The multiple roles of PTEN in tumor suppression. Cell 100(4), 387–390 (2000).
pubmed: 10693755 doi: 10.1016/S0092-8674(00)80674-1
Bebelman, M. P. et al. Biogenesis and function of extracellular vesicles in cancer. Pharmacol. Ther. 188, 1–11 (2018).
pubmed: 29476772 doi: 10.1016/j.pharmthera.2018.02.013
Uzoh, C. C. et al. PTEN-mediated pathways and their association with treatment-resistant prostate cancer. BJU Int. 104(4), 556–561 (2009).
pubmed: 19220271 doi: 10.1111/j.1464-410X.2009.08411.x
Milella, M. et al. PTEN: Multiple functions in human malignant tumors. Front. Oncol. 5, 24 (2015).
pubmed: 25763354 pmcid: 4329810 doi: 10.3389/fonc.2015.00024
Gabriel, K. et al. Regulation of the tumor suppressor PTEN through exosomes: A diagnostic potential for prostate cancer. PLoS ONE 8(7), e70047 (2013).
pubmed: 23936141 pmcid: 3723640 doi: 10.1371/journal.pone.0070047
Borcherding, N. et al. ROR1, an embryonic protein with an emerging role in cancer biology. Protein Cell 5(7), 496–502 (2014).
pubmed: 24752542 pmcid: 4085287 doi: 10.1007/s13238-014-0059-7
Yamada, T. et al. Comparison of methods for isolating exosomes from bovine milk. J. Vet. Med. Sci. 74(11), 1523–1525 (2012).
pubmed: 22785357 doi: 10.1292/jvms.12-0032
Linares, R. et al. High-speed centrifugation induces aggregation of extracellular vesicles. J. Extracell. Vesicles 4, 29509 (2015).
pubmed: 26700615 doi: 10.3402/jev.v4.29509
Maas, S. L. et al. Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics. J. Control Release 200, 87–96 (2015).
pubmed: 25555362 pmcid: 4324667 doi: 10.1016/j.jconrel.2014.12.041
Geeurickx, E. et al. The generation and use of recombinant extracellular vesicles as biological reference material. Nat. Commun. 10(1), 3288 (2019).
pubmed: 31337761 pmcid: 6650486 doi: 10.1038/s41467-019-11182-0
Gorgens, A. et al. Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material. J. Extracell. Vesicles 8(1), 1587567 (2019).
pubmed: 30949308 pmcid: 6442110 doi: 10.1080/20013078.2019.1587567
Taylor, D. D. & Shah, S. Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods 87, 3–10 (2015).
pubmed: 25766927 doi: 10.1016/j.ymeth.2015.02.019
Dhondt, B. et al. Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine. J. Extracell. Vesicles 9(1), 1736935 (2020).
pubmed: 32284825 pmcid: 7144211 doi: 10.1080/20013078.2020.1736935
Hopkins, B. D. et al. A secreted PTEN phosphatase that enters cells to alter signaling and survival. Science 341(6144), 399–402 (2013).
pubmed: 23744781 pmcid: 3935617 doi: 10.1126/science.1234907
Cheruvanky, A. et al. Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. Am. J. Physiol. Renal Physiol. 292(5), F1657–F1661 (2007).
pubmed: 17229675 doi: 10.1152/ajprenal.00434.2006
Vergauwen, G. et al. Confounding factors of ultrafiltration and protein analysis in extracellular vesicle research. Sci. Rep. 7(1), 2704 (2017).
pubmed: 28577337 pmcid: 5457435 doi: 10.1038/s41598-017-02599-y
Nordin, J. Z. et al. Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties. Nanomedicine 11(4), 879–883 (2015).
pubmed: 25659648 doi: 10.1016/j.nano.2015.01.003
Osteikoetxea, X. et al. Differential detergent sensitivity of extracellular vesicle subpopulations. Org. Biomol. Chem. 13(38), 9775–9782 (2015).
pubmed: 26264754 doi: 10.1039/C5OB01451D
Yoshioka, Y. et al. Comparative marker analysis of extracellular vesicles in different human cancer types. J. Extracell Vesicles. 2, 20424 (2013).
doi: 10.3402/jev.v2i0.20424
Li, J. et al. Serum-free culture alters the quantity and protein composition of neuroblastoma-derived extracellular vesicles. J. Extracell. Vesicles 4, 26883 (2015).
pubmed: 26022510 doi: 10.3402/jev.v4.26883
Hurwitz, S. N. et al. Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget 7(52), 86999–87015 (2016).
pubmed: 27894104 pmcid: 5341331 doi: 10.18632/oncotarget.13569
Sharp, A. et al. Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer. J. Clin. Invest. 129(1), 192–208 (2019).
pubmed: 30334814 doi: 10.1172/JCI122819
Jorgensen, M. et al. Extracellular Vesicle (EV) Array: Microarray capturing of exosomes and other extracellular vesicles for multiplexed phenotyping. J. Extracell. Vesicles 2, 20920 (2013).
doi: 10.3402/jev.v2i0.20920

Auteurs

Susann Allelein (S)

Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany. susann.allelein@izi.fraunhofer.de.

Paula Medina-Perez (P)

Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.

Ana Leonor Heitor Lopes (ALH)

Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.

Sabrina Rau (S)

Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.

Gerd Hause (G)

Martin Luther University Halle-Wittenberg, Biocenter, Halle (Saale), Germany.

Andreas Kölsch (A)

Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.

Dirk Kuhlmeier (D)

Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH